(NYSE: GKOS) Glaukos's forecast annual revenue growth rate of 18.77% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 6.74%, and it is also forecast to beat the US market's average forecast revenue growth rate of 8.33%.
Glaukos's revenue in 2024 is $341,725,000.On average, 9 Wall Street analysts forecast GKOS's revenue for 2024 to be $20,550,867,211, with the lowest GKOS revenue forecast at $20,411,897,500, and the highest GKOS revenue forecast at $20,650,931,997. On average, 9 Wall Street analysts forecast GKOS's revenue for 2025 to be $25,932,715,165, with the lowest GKOS revenue forecast at $24,068,301,042, and the highest GKOS revenue forecast at $27,408,189,940.
In 2026, GKOS is forecast to generate $33,056,987,224 in revenue, with the lowest revenue forecast at $28,154,417,173 and the highest revenue forecast at $35,820,116,105.